Paderes, Manilyn .
HRN: 23-13-25 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/11/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
06/11/2023
06/17/2023
IVT
500 Mg
Q 8 Hrs
LTCS
Waiting Final Action
Indication: Empiric Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes